Fox Business - The Power to Prosper
Search Site

Merck

Is a cat the ideal symbol of Libertarian thought?

The Independents read some recent viewer questions, comments an criticisms.

Read More

  1. Bull vs bear debate

    Hedgeye CEO Keith McCullough and Altaira Senior Managing Director Ralph Acampora discuss their outlooks for the economy and markets.

  2. Ebola stock watch

    FBN’s Liz MacDonald on the latest developments from Merck and NewLink’s Ebola vaccine tests.

  3. More stimulus from the ECB?

    Canaccord Genuity U.S. Portfolio Strategy Tony Dwyer and Merk Investments President Axel Merk discuss their outlook for the ECB.

  4. Stossel 11/6/2014: And the winner is...

    What do the results of the midterm elections mean for freedom?

  5. Johnny Depp drunk during speech at Hollywood Film Awards?

    The Hollywood and Vine panel weighs in on Taylor Swift, Bill Cosby, Johnny Depp’s speech at the Hollywood Film Awards and Bono’s bike accident.

  6. Cubist Pharmaceuticals a long-term buy?

    FBN’s Charles Payne, NewOak Capital President James Frischling, small business expert Susan Solovic, retail analyst Hitha Prabhakar and Penn Financial Group founder Matt McCall on the outlook for Cubist Pharmaceuticals.

  7. Pfizer, Merck reach deal to develop tumor treatment

    FBN’s Ashley Webster breaks down the details of Pfizer’s cancer drug deal with Merck .

  8. Cheap and ignored blue-chip stocks

    Fort Pitt Capital Group V.P. Kim Forrest, Athena Advisor Services Senior V.P. Dan Stecich and FBN’s Cheryl Casone on Apple’s milestone, UPS’s new business plan and top stocks.

  9. Hailo Founder: Growth areas for E-Hail are in Europe, Asia

    Hailo Founder Jay Bregman and Nylon Media CEO Paul Greenberg discusses rapid growth overseas and his decision to stop doing business in the U.S.

  10. Dow, S&P close at record high

    Adviser Investment Management Chief Investment Strategist Jim Lowell, A&G Capital CIO Hilary Kramer and Trading Advantage Senior Market Strategist Scott Bauer on the outlook for the markets and where the opportunities are for investors.

  11. BNP N. America CEO bullish on economy

    BNP Paribas North America CEO Jean-Yves Fillion weighs in on the economy and how clients are benefitting from a low-rate environment.

  12. Retailers working on Apple Pay competitor?

    Wearables.com CEO Luis Rincon on the retailers that have shut down access to Apple Pay.

  1. Knowing when to take a loss

    FBN’s Charles Payne, NewOak Capital President James Frischling, Sterne Agee Chief Economist Lindsey Piegza, FNC contributor Jonathan Hoenig, retail analyst Hitha Herzog and Penn Financial Group founder Matt McCall review some of the show’s stock picks.

  2. China impacting U.S. market selloff?

    Athena Capital Advisors CEO and Founder Lisette Cooper on the U.S. and global markets, oil prices and the Fed.

  3. New Merck drug shows promise fighting cancer

    NYU School of Medicine’s Dr. Devi Nampiaparampil discusses the effectiveness of Merck ’s new cancer drug.

  4. Merck CEO on $8.4B Cubist deal

    Merck CEO Kenneth Frazier discusses the motivation behind the $8.4 billion deal to buy Cubist, and the drugmaker’s strategy to constantly look for value-creating opportunities.

  5. Big year for M&A

    Rich Jeanneret of EY Transaction Advisory Services says cash and confidence are behind strong deal making.

  6. 2015: The best year in a decade?

    John Spallanzani GFI Group gives his outlook for year-end cash flow and explains why Jamie Dimon is his pick for business person of the year.

  7. Merck to acquire Cubist Pharmaceuticals

    FBN’s Ashley Webster breaks down the details of Merck ’s acquisition of Cubist Pharmaceuticals.

‹ Prev12345Next ›
Freebase CC-BY
Source: Merck on Freebase, licensed under CC-BY
Other content from Wikipedia, licensed under the GFDL